{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T19:16:04Z","timestamp":1794770164315,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":34,"publisher":"Springer US","isbn-type":[{"value":"9781071637296","type":"print"},{"value":"9781071637302","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3730-2_14","type":"book-chapter","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T06:58:37Z","timestamp":1710313117000},"page":"191-204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Co-Delivery Polymeric Poly(Lactic-Co-Glycolic Acid) (PLGA) Nanoparticles to Target Cancer Stem-Like Cells"],"prefix":"10.1007","author":[{"given":"Catherine S.","family":"Snyder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Repetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Burkhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Tuteja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"22832","DOI":"10.18632\/oncotarget.25126","volume":"9","author":"A Ghoneum","year":"2018","unstructured":"Ghoneum A, Afify H, Salih Z et al (2018) Role of tumor microenvironment in ovarian cancer pathobiology. Oncotarget 9:22832\u201322849","journal-title":"Oncotarget"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.biocel.2018.12.010","volume":"107","author":"LF Al-Alem","year":"2019","unstructured":"Al-Alem LF, Pandya UM, Baker AT et al (2019) Ovarian cancer stem cells: what progress have we made? Int J Biochem Cell Biol 107:92\u2013103","journal-title":"Int J Biochem Cell Biol"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12943-017-0638-3","volume":"16","author":"M Lupia","year":"2017","unstructured":"Lupia M, Cavallaro U (2017) Ovarian cancer stem cells: still an elusive entity? Mol Cancer 16:64","journal-title":"Mol Cancer"},{"key":"14_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/cancers11010021","volume":"11","author":"MS Stack","year":"2018","unstructured":"Stack MS, Nephew KP, Burdette JE, Mitra AK (2018) The tumor microenvironment of high grade serous ovarian cancer. Cancers (Basel) 11:21","journal-title":"Cancers (Basel)"},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1158\/1078-0432.CCR-11-2188","volume":"18","author":"AD Steg","year":"2012","unstructured":"Steg AD, Bevis KS, Katre AA et al (2012) Stem cell pathways contribute to clinical chemoresistance in ovarian cancer. Clin Cancer Res 18:869\u2013881","journal-title":"Clin Cancer Res"},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s13238-017-0466-7","volume":"9","author":"B Zhang","year":"2018","unstructured":"Zhang B, Chen F, Xu Q et al (2018) Revisiting ovarian cancer microenvironment: a friend or a foe? Protein Cell 9:674\u2013692","journal-title":"Protein Cell"},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1158\/0008-5472.CAN-10-3175","volume":"71","author":"IA Silva","year":"2011","unstructured":"Silva IA, Bai S, McLean K et al (2011) Aldehyde dehydrogenase in combination with CD133 defines Angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res 71:3991\u20134001","journal-title":"Cancer Res"},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1158\/1535-7163.MCT-10-0563","volume":"9","author":"CN Landen","year":"2010","unstructured":"Landen CN, Goodman B, Katre AA et al (2010) Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer. Mol Cancer Ther 9:3186\u20133199","journal-title":"Mol Cancer Ther"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/modpathol.2011.170","volume":"25","author":"J Zhang","year":"2012","unstructured":"Zhang J, Guo X, Chang DY et al (2012) CD133 expression associated with poor prognosis in ovarian cancer. Mod Pathol 25:456","journal-title":"Mod Pathol"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1002\/stem.236","volume":"27","author":"MD Curley","year":"2009","unstructured":"Curley MD, Therrien VA, Cummings CL et al (2009) CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells 27:2875\u20132883","journal-title":"Stem Cells"},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ygyno.2016.03.022","volume":"142","author":"AC Sharrow","year":"2016","unstructured":"Sharrow AC, Perkins B, Collector MI et al (2016) Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: towards targeted stem cell therapy. Gynecol Oncol 142:341\u2013348","journal-title":"Gynecol Oncol"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ijc.25967","volume":"130","author":"I Kryczek","year":"2012","unstructured":"Kryczek I, Liu S, Roh M et al (2012) Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Int J Cancer 130:29\u201339","journal-title":"Int J Cancer"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"6916","DOI":"10.18632\/oncotarget.6870","volume":"7","author":"LG Coffman","year":"2016","unstructured":"Coffman LG, Choi Y-J, McLean K et al (2016) Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4\/HH signaling loop. Oncotarget 7:6916\u20136932","journal-title":"Oncotarget"},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ygyno.2011.08.005","volume":"123","author":"JA Cho","year":"2011","unstructured":"Cho JA, Park H, Lim EH et al (2011) Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts. Gynecol Oncol 123:379\u2013386","journal-title":"Gynecol Oncol"},{"key":"14_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature06188","volume":"449","author":"AE Karnoub","year":"2007","unstructured":"Karnoub AE, Dash AB, Vo AP et al (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557\u2013563","journal-title":"Nature"},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.7150\/jca.16116","volume":"7","author":"D-C Ding","year":"2016","unstructured":"Ding D-C, Liu H-W, Chu T-Y (2016) Interleukin-6 from ovarian mesenchymal stem cells promotes proliferation, sphere and Colony formation and tumorigenesis of an ovarian cancer cell line SKOV3. J Cancer 7:1815\u20131823","journal-title":"J Cancer"},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1172\/JCI45273","volume":"121","author":"K McLean","year":"2011","unstructured":"McLean K, Gong Y, Choi Y et al (2011) Human ovarian carcinoma\u2013associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest 121:3206\u20133219","journal-title":"J Clin Invest"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3390\/cancers12082063","volume":"12","author":"S Raghavan","year":"2020","unstructured":"Raghavan S, Snyder CS, Wang A et al (2020) Carcinoma-associated mesenchymal stem cells promote chemoresistance in ovarian cancer stem cells via PDGF signaling. Cancers (Basel) 12:2063","journal-title":"Cancers (Basel)"},{"key":"14_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM et al (2021) Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 20:101","journal-title":"Nat Rev Drug Discov"},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3390\/nano10071403","volume":"10","author":"B Begines","year":"2020","unstructured":"Begines B, Ortiz T, P\u00e9rez-Aranda M et al (2020) Polymeric nanoparticles for drug delivery: recent developments and future prospects. Nanomaterials 10:1403","journal-title":"Nanomaterials"},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jconrel.2008.09.086","volume":"133","author":"F Danhier","year":"2009","unstructured":"Danhier F, Lecouturier N, Vroman B et al (2009) Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Control Release 133:11\u201317","journal-title":"J Control Release"},{"key":"14_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0168-3659(02)00212-2","volume":"83","author":"C Fonseca","year":"2002","unstructured":"Fonseca C, Sim\u00f5es S, Gaspar R (2002) Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release 83:273\u2013286","journal-title":"J Control Release"},{"key":"14_CR23","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s13346-013-0162-y","volume":"3","author":"M Li","year":"2013","unstructured":"Li M, Czyszczon EA, Reineke JJ (2013) Delineating intracellular pharmacokinetics of paclitaxel delivered by PLGA nanoparticles. Drug Deliv Transl Res 3:551\u2013561","journal-title":"Drug Deliv Transl Res"},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0168-3659(02)00320-6","volume":"86","author":"L Mu","year":"2003","unstructured":"Mu L, Feng SS (2003) A novel controlled release formulation for the anticancer drug paclitaxel (Taxol\u00ae): PLGA nanoparticles containing vitamin E TPGS. J Control Release 86:33\u201348","journal-title":"J Control Release"},{"key":"14_CR25","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.4314\/tjpr.v17i7.6","volume":"17","author":"AS Alshetaili","year":"2018","unstructured":"Alshetaili AS, Anwer MK, Alshahrani SM et al (2018) Characteristics and anticancer properties of Sunitinib malate-loaded poly-lactic-co-glycolic acid nanoparticles against human colon cancer HT-29 cells lines. Trop J Pharm Res 17:1263\u20131269","journal-title":"Trop J Pharm Res"},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.ijbiomac.2015.10.079","volume":"82","author":"JJ Joseph","year":"2016","unstructured":"Joseph JJ, Sangeetha D, Gomathi T (2016) Sunitinib loaded chitosan nanoparticles formulation and its evaluation. Int J Biol Macromol 82:952\u2013958","journal-title":"Int J Biol Macromol"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ijpharm.2016.12.016","volume":"517","author":"MM Saber","year":"2017","unstructured":"Saber MM, Bahrainian S, Dinarvand R, Atyabi F (2017) Targeted drug delivery of Sunitinib Malate to tumor blood vessels by cRGD-chiotosan-gold nanoparticles. Int J Pharm 517:269\u2013278","journal-title":"Int J Pharm"},{"key":"14_CR28","first-page":"3099","volume":"28","author":"AZ Dudek","year":"2008","unstructured":"Dudek AZ, Nguyen S (2008) Safety of nab-paclitaxel plus Sunitinib: analysis of three cases. Anticancer Res 28:3099\u20133105","journal-title":"Anticancer Res"},{"key":"14_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10143","volume":"4","author":"AC Anselmo","year":"2019","unstructured":"Anselmo AC, Mitragotri S (2019) Nanoparticles in the clinic: an update. Bioeng Transl Med 4:e10143","journal-title":"Bioeng Transl Med"},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1586\/erd.12.58","volume":"9","author":"L Zhang","year":"2012","unstructured":"Zhang L, Huang J, Si T, Xu RX (2012) Coaxial electrospray of microparticles and nanoparticles for biomedical applications. Expert Rev Med Devices 9:595\u2013612","journal-title":"Expert Rev Med Devices"},{"key":"14_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-1-4939-7401-6_6","volume-title":"Methods in molecular biology: cancer stem cells: methods and protocols","author":"P Mehta","year":"2018","unstructured":"Mehta P, Novak C, Raghavan S et al (2018) Self-renewal and CSCs in vitro enrichment: growth as floating spheres. In: Papaccio G, Desiderio V (eds) Methods in molecular biology: cancer stem cells: methods and protocols, pp 61\u201375"},{"key":"14_CR32","doi-asserted-by":"publisher","unstructured":"Bregenzer ME, Davis C, Horst EN et al (2019) Physiologic patient derived 3d spheroids for anti-neoplastic drug screening to target cancer stem cells. J Vis Exp 2019. https:\/\/doi.org\/10.3791\/59696","DOI":"10.3791\/59696"},{"key":"14_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-1-0716-1956-8_15","volume":"2424","author":"M Bregenzer","year":"2022","unstructured":"Bregenzer M, Horst E, Mehta P et al (2022) The role of the tumor microenvironment in CSC enrichment and Chemoresistance: 3D co-culture methods. Methods Mol Biol 2424:217\u2013245","journal-title":"Methods Mol Biol"},{"key":"14_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jcis.2013.11.037","volume":"417","author":"B Almer\u00eda","year":"2014","unstructured":"Almer\u00eda B, Gomez A (2014) Electrospray synthesis of monodisperse polymer particles in a broad (60nm\u20132\u03bcm) diameter range: guiding principles and formulation recipes. J Colloid Interface Sci 417:121\u2013130","journal-title":"J Colloid Interface Sci"}],"container-title":["Methods in Molecular Biology","Cancer Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3730-2_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T06:59:37Z","timestamp":1710313177000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3730-2_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9781071637296","9781071637302"],"references-count":34,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3730-2_14","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-0716-3730-2","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"14 March 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}